Abbott Laboratories (ABT) Stock Forecast
US · Healthcare
Current price
$93.24
Market cap
$162.41B
Mean price target
$116.54
Implied upside
25.0%
Key takeaways
- Analysts rate Abbott Laboratories a “Buy”, with a mean price target of $116.54 — about 25.0% upside from the current $93.24, based on 24 analysts.
- ABT is trading in the middle of its 52-week range, at 20% of the $81.97–$137.54 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 24 |
| Mean target | $116.54 |
| High target | $135.00 |
| Low target | $92.00 |
| Rating split (SB / B / H / S / SS) | 6 / 16 / 7 / 0 / 0 |
Price & trading
| Current price | $93.24 |
|---|---|
| Previous close | $90.49 |
| 52-week high | $137.54 |
| 52-week low | $81.97 |
| 50-day average | $89.43 |
| Beta | 0.62 |
See the full ABT breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Abbott Laboratories (ABT) share price?
- Abbott Laboratories last traded at $93.24 with a market capitalisation of about $162.4B.
- What is the analyst price target for ABT?
- The mean analyst price target for Abbott Laboratories is $116.54, roughly 25.0% above the latest price. The current consensus rating is “Buy”.
- Where can I see Abbott Laboratories's full financial metrics?
- Luminoso tracks ABT's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.